Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers [Phase 2]
Phase 2 clinical trial update describing stem cell transplantation for participants with germline RUNX1-associated blood cancers; the trial …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Natural History Study of Early Life Exposures in Agriculture (ELEA)
An update on the ELEA natural history study sponsored by the National Cancer Institute investigating how early life exposures in agriculture…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
This update describes improved methods for selecting donor cells used in bone marrow transplant alternatives, and the trial is currently rec…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
A clinical trial update describing cognitive aftereffects of neurotoxicity in children and young adults with relapsed/refractory hematologic…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Familial Investigations of Childhood Cancer Predisposition
An ongoing St. Jude-led clinical trial is investigating familial cancer predisposition syndromes in children and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Managed Access Programs for CTL019, Tisagenlecleucel
Novartis’ CAR-T therapy tisagenlecleucel (CTL019) is the subject of a clinical trial update focused on managed access programs, including ly…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) [Phase 1, Phase 2]
A Phase 1/2 clinical trial (cAMeLot-1) is evaluating Bleximenib in participants with acute leukemia. The study is currently in recruitment.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy [NA]
This clinical trial update outlines a study to define the role of palliative care for patients with hematologic malignancies undergoing adop…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
The document reports specimen collection activities for the Agricultural Health Study pesticide exposure cohort, a National Cancer Institute…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Epidemiological Study of Korean Radiation Workers
An epidemiological study in Korea examining occupational radiation exposure and the associated risk of radiation-induced neoplasms and leuke…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
A clinical trial update describing leukapheresis collection for manufacturing CAR or adoptive cell therapies, with enrollment by invitation …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia. [Phase 1, Phase 2]
This clinical trial update outlines a Phase 1/2 study evaluating radioligand therapy with [177Lu]Lu-PentixaTher targeting CXCR4 in relapsed/…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Pre-malignant States to Hematologic Malignancies in Firefighters
A Wake Forest trial investigates progression from pre-malignant hematologic states to blood cancers in firefighters and is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating the combination of trametinib and azacitidine for newly diagnosed juvenile myelomonocytic leukemia (J…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating CD45RA-depleted stem cell addback to prevent viral or fungal infections following TCRab/CD19-deplet…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients [Phase 1]
A Phase Ia/Ib clinical trial update describes testing Revumenib in combination with cytarabine, daunorubicin, and gemtuzumab ozogamicin in f…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia [Phase 1]
A Phase 1 clinical trial evaluating a radiolabeled 14C-Bleximenib in patients with acute leukemia. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies [Phase 3]
A Phase 3 clinical trial comparing haploidentical hematopoietic stem cell transplantation from young non-first-degree donors versus older fi…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. [Phase 1]
Arovella Therapeutics reports a Phase 1 study of ALA-101 in CD19-positive Non-Hodgkin lymphoma and leukemia; the trial is not yet recruiting…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft [Phase 1]
A Stanford-sponsored Phase 1 trial is evaluating reduced-intensity, allogeneic hematopoietic cell transplantation with a T-cell–depleted gra…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT) [NA]
This clinical trial update describes a study evaluating reduced-intensity conditioning with 200 cGy versus 400 cGy total body irradiation in…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) [Phase 2]
This update notes that the BMT-06 study of intensity-modulated total marrow irradiation (IM-TMI) is a Phase 2 trial currently recruiting for…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials [NA]
A clinical trial update describing efforts to improve adolescent and young adult self-reported data in ECOG-ACRIN trials, with trials curren…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies [Phase 1]
Phase 1 trial evaluating an anti-CD30 bispecific antibody (AATC) in relapsed/refractory CD30-positive hematologic malignancies; currently re…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]
Clinical trial update for Allo-QuadCAR01-T, an allogeneic CD19/CD20 CAR-T, in relapsed or refractory B-cell malignancies, currently recruiti…